Cost Implications of Left Atrial Appendage Occlusion During Cardiac Surgery: A Cost Analysis of the LAAOS III Trial
Journal of the American Heart Association · 2023
DOI: 10.1161/jaha.122.028716 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2023. Verfasst von Adam Eqbal und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery McMaster University Ontario Hamilton Canada. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Appendage, Cardiac Surgical Procedures, Stroke. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CIHR.
Abstract (Originalsprache)
Background
The LAAOS III (Left Atrial Appendage Occlusion Study) clinical trial demonstrated that concomitant left atrial appendage (LAA) occlusion leads to a lower risk of ischemic stroke or systemic embolism compared with no occlusion in participants with atrial fibrillation and a CHA 2 DS 2 ‐VASc score of ≥2 undergoing cardiac surgery for another indication. We report the cost implications of concomitant LAA occlusion during cardiac surgery. Methods and Results Using LAAOS III data, we compared the costs (in US dollars) associated with LAA occlusion to no occlusion from the perspective of the Centers for Medicare and Medicaid Services. We calculated the average cost per participant during the trial by applying Medicare reimbursement costs to cardiovascular events for all trial participants. We conducted sensitivity analyses, varying the cost of stroke ±25% and occlusion technique use. Cost neutrality was defined as a mean cost difference within ±5% of the cost per participant in the no‐occlusion group. Total study cost per participant was $3878 in the LAA occlusion group and $4490 in the no‐occlusion group, a mean difference of −$612 (95% CI, −$1276 to $45). The main drivers of cost savings were fewer stroke events during the trial (mean difference of −$1021). In sensitivity analyses, LAA occlusion was cost saving for suture and stapler techniques but more expensive with closure device.
Conclusions
Concomitant LAA occlusion was cost saving for participants in LAAOS III. Our findings support concomitant LAA occlusion as an economically dominant strategy for patients with atrial fibrillation and a CHA 2 DS 2 ‐VASc score of ≥2 undergoing cardiac surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery McMaster University Ontario Hamilton Canada.
- Population Health Research Institute McMaster University Ontario Hamilton Canada.
- Division of Cardiology McMaster University Ontario Hamilton Canada.
- Division of Cardiac Surgery Santa Maria Hospital, Gruppo Villa Maria Care and Research Bari Italy.
- Department of Medical and Surgical Science University of Foggia Foggia Italy.
- E. Meshalkin National Medical Research Center Novosibirsk Russia.
ORCID-Profile: Adam Eqbal, Wesley Tong, Andre Lamy, Emilie Belley-Cote, Domenico Paparella, Alistair G Royse, Wilko Reents, P J Deveraux, Katheryn Brady, Jessica Vincent, Stuart J Connolly, Richard P Whitlock
Förderung
- CIHR
Zitieren
APA
Eqbal, A., Tong, W., Lamy, A., Belley-Cote, E., Paparella, D., Bogachev-Prokophiev, A., Royse, A. G., Reents, W., Deveraux, P. J., Brady, K., Vincent, J., Connolly, S. J., Whitlock, R. P., & LAAOS III Investigators (2023). Cost Implications of Left Atrial Appendage Occlusion During Cardiac Surgery: A Cost Analysis of the LAAOS III Trial. Journal of the American Heart Association. https://doi.org/10.1161/jaha.122.028716
Vancouver
Eqbal A, Tong W, Lamy A, Belley-Cote E, Paparella D, Bogachev-Prokophiev A, et al. Cost Implications of Left Atrial Appendage Occlusion During Cardiac Surgery: A Cost Analysis of the LAAOS III Trial. Journal of the American Heart Association. 2023. doi:10.1161/jaha.122.028716
BibTeX
@article{Eqbal2023,
author = {Eqbal, Adam and Tong, Wesley and Lamy, Andre and Belley-Cote, Emilie and Paparella, Domenico and Bogachev-Prokophiev, Alexander and Royse, Alistair G and Reents, Wilko and Deveraux, P J and Brady, Katheryn and Vincent, Jessica and Connolly, Stuart J and Whitlock, Richard P and LAAOS III Investigators, LAAOS III Investigators},
title = {Cost Implications of Left Atrial Appendage Occlusion During Cardiac Surgery: A Cost Analysis of the LAAOS III Trial},
journal = {Journal of the American Heart Association},
year = {2023},
doi = {10.1161/jaha.122.028716}
}
EUVIMED